Yes. Pre-clinical studies have shown that Prelivia increases local blood circulation by 28%(1), resulting in an 80% decrease in pressure injury damage(2). Prelivia was tested on 68 at-risk patients across four different healthcare settings. None of these patients developed a pressure injury while being treated,(3) while 100% of them responded positively to continuous use.(4)
(1) Gyawali, et. al., J Appl Physiol. 110 :246-255, 2011 | (2) Solis, et al., J Appl Physiol, 114 :286-296, 2013 | (3) Ahmetovic, et al, Adv Wound Caref, 4(3): 192-201, 2015. Kane, et al, Adv Wound Care, 6(4): 115-124, 2017 | (4) Chan, et al; 2015
Please click here to access our Prelivia scientific data package.